$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000087786016000126 Filed on May 06, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$59.02M	$55.75M
YoY Change	5.86%	29.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.340M	$4.180M
YoY Change	-20.1%	26.28%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.73M	$13.00M
YoY Change	5.64%	41.3%
% of Gross Profit
Operating Expenses	$27.33M	$25.60M
YoY Change	6.77%	103.99%
Operating Profit	$31.69M
YoY Change
Interest Expense	$10.26M	$8.412M
YoY Change	21.99%	-224.99%
% of Operating Profit	32.39%
Other Income/Expense, Net	$160.0K	$90.00K
YoY Change	77.78%
Pretax Income	$31.69M	$30.15M
YoY Change	5.09%	26.36%
Income Tax
% Of Pretax Income
Net Earnings	$32.73M	$29.68M
YoY Change	10.25%	26.13%
Net Earnings / Revenue	55.45%	53.24%
Basic Earnings Per Share	$0.85	$0.79
Diluted Earnings Per Share	$0.85	$0.79
COMMON SHARES
Basic Shares Outstanding	38.40M shares	37.56M shares
Diluted Shares Outstanding	38.41M shares	37.65M shares

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.197M	$4.200M
YoY Change	-0.07%	-32.26%
Cash & Equivalents	$4.197M	$14.20M
Short-Term Investments	$0.00
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$4.000M	$2.900M
Other Receivables	$65.00M	$41.30M
Total Short-Term Assets	$97.80M	$48.40M
YoY Change	102.07%	54.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.841B	$1.768B
YoY Change	4.15%	37.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.254M	$63.70M
YoY Change	-88.61%	4.08%
Other Assets	$3.800M	$25.80M
YoY Change	-85.27%	9.79%
Total Long-Term Assets	$2.061B	$1.971B
YoY Change	4.57%	36.72%
TOTAL ASSETS
Total Short-Term Assets	$97.80M	$48.40M
Total Long-Term Assets	$2.061B	$1.971B
Total Assets	$2.159B	$2.020B
YoY Change	6.91%	37.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.80M	$14.80M
YoY Change	67.57%	108.45%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$80.60M	$68.00M
YoY Change	18.53%	22.97%
LONG-TERM LIABILITIES
Long-Term Debt	$937.1M	$899.4M
YoY Change	4.19%	42.99%
Other Long-Term Liabilities	$1.800M	$5.800M
YoY Change	-68.97%	1.75%
Total Long-Term Liabilities	$938.9M	$905.2M
YoY Change	3.72%	42.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.60M	$68.00M
Total Long-Term Liabilities	$938.9M	$905.2M
Total Liabilities	$1.020B	$983.2M
YoY Change	3.7%	40.36%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.086B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.131B	$1.037B
YoY Change
Total Liabilities & Shareholders Equity	$2.159B	$2.020B
YoY Change	6.91%	37.1%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	$32.73M	$29.68M
YoY Change	10.25%	26.13%
Depreciation, Depletion And Amortization	$13.73M	$13.00M
YoY Change	5.64%	41.3%
Cash From Operating Activities	$41.30M	$38.56M
YoY Change	7.09%	33.44%
INVESTING ACTIVITIES
Capital Expenditures	-$9.500M	-$3.200M
YoY Change	196.88%	-83.07%
Acquisitions
YoY Change
Other Investing Activities	-$4.800M	-$39.80M
YoY Change	-87.94%	1183.87%
Cash From Investing Activities	-$14.30M	-$43.06M
YoY Change	-66.8%	95.73%
FINANCING ACTIVITIES
Cash Dividend Paid	$32.64M	$28.86M
YoY Change	13.07%
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net	$189.0K	$183.0K
YoY Change	3.28%
Cash From Financing Activities	-$11.48M	$5.400M
YoY Change	-312.57%	-145.38%
NET CHANGE
Cash From Operating Activities	$41.30M	$38.56M
Cash From Investing Activities	-$14.30M	-$43.06M
Cash From Financing Activities	-$11.48M	$5.400M
Net Change In Cash	$15.52M	$903.0K
YoY Change	1618.94%	-118.06%
FREE CASH FLOW
Cash From Operating Activities	$41.30M	$38.56M
Capital Expenditures	-$9.500M	-$3.200M
Free Cash Flow	$50.80M	$41.76M
YoY Change	21.63%	-12.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38429510	shares
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2015Q1	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	820000	USD
CY2016Q1	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	868000	USD
CY2015Q1	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	0.85
CY2016Q1	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	0.90
CY2016Q1	nhi	Convertible Debt Instrument Conversion Ratio Principal Amount Basis ConvertibleDebtInstrumentConversionRatioPrincipalAmountBasis	1000	USD
CY2016Q1	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
CY2016Q1	nhi	Credit Facility Expansion Amount CreditFacilityExpansionAmount	250000000	USD
CY2016Q1	nhi	Debt Instrument Variable Interest Rate Reference Rate Basis Points DebtInstrumentVariableInterestRateReferenceRateBasisPoints	44
CY2015Q1	nhi	Depreciation Continuing Operations DepreciationContinuingOperations	13014000	USD
CY2016Q1	nhi	Depreciation Continuing Operations DepreciationContinuingOperations	13733000	USD
CY2015Q1	nhi	Equity Issuance Costs EquityIssuanceCosts	-200000	USD
CY2016Q1	nhi	Equity Issuance Costs EquityIssuanceCosts	0	USD
CY2015Q1	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	226000	USD
CY2016Q1	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	283000	USD
CY2016Q1	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	20000	shares
CY2016Q1	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	976000	USD
CY2016Q1	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	9	properties
CY2016Q1	nhi	Number Of Lessees NumberOfLessees	26
CY2016Q1	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	2112897000	USD
CY2015Q4	nhi	Real Estate Purchase Liabilities RealEstatePurchaseLiabilities	750000	USD
CY2016Q1	nhi	Real Estate Purchase Liabilities RealEstatePurchaseLiabilities	750000	USD
CY2015Q1	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	255000	USD
CY2016Q1	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	0	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	19397000	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	24805000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	259059000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	272783000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27910000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	26268000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1085136000	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1085896000	USD
CY2016Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	219000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1464000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	979000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2015Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	0	USD
CY2016Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	68000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	833000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	885000	USD
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5666	shares
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75050	shares
CY2015Q4	us-gaap	Assets Assets	2133218000	USD
CY2016Q1	us-gaap	Assets Assets	2159234000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	34667000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	37492000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3287000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4190000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	903000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15522000	USD
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	31467000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13286000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28808000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	13011000	USD
CY2016Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	18702000	USD
CY2014Q1	us-gaap	Convertible Debt ConvertibleDebt	192238000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Convertible Debt ConvertibleDebt	194138000	USD
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2016Q1	us-gaap	Convertible Debt ConvertibleDebt	194420000	USD
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38396727	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38403978	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38396727	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38403978	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	384000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	384000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27280000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31083000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	330000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	384000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	27610000	USD
CY2015Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	19862000	USD
CY2016Q1	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	18024000	USD
CY2016Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	955503000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	7762000	USD
CY2016Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	71.81
CY2016Q1	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	13.926
CY2016Q1	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	2785200	shares
CY2016Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.039
CY2016Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7132000	USD
CY2015Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	914443000	USD
CY2016Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	937138000	USD
CY2015Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	15544000	USD
CY2016Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	15022000	USD
CY2015Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	59777000	USD
CY2016Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	65062000	USD
CY2015Q4	us-gaap	Deferred Revenue DeferredRevenue	2256000	USD
CY2016Q1	us-gaap	Deferred Revenue DeferredRevenue	1013000	USD
CY2015Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	13014000	USD
CY2016Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	13733000	USD
CY2016Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	34563000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32637000	USD
CY2016Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	34564000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1151000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	7657000	USD
CY2016Q1	us-gaap	Equity Method Investments EquityMethodInvestments	7254000	USD
CY2015Q4	us-gaap	Escrow Deposit EscrowDeposit	4631000	USD
CY2016Q1	us-gaap	Escrow Deposit EscrowDeposit	3783000	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1654000	USD
CY2015Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
CY2016Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1654000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3845000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2929000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	30150000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31685000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.79
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.85
CY2015Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-229000	USD
CY2016Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-402000	USD
CY2015Q1	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-92000	USD
CY2016Q1	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-161000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3290000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	491000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1756000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1243000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-634000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-110000	USD
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	18941	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68257	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	13144	shares
CY2015Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	-120000	USD
CY2016Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	-121000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	8412000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	10262000	USD
CY2015Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7712000	USD
CY2016Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9515000	USD
CY2015Q1	us-gaap	Interest Income Operating InterestIncomeOperating	2121000	USD
CY2016Q1	us-gaap	Interest Income Operating InterestIncomeOperating	3092000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	7194000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	7682000	USD
CY2015Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1945323000	USD
CY2016Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1954537000	USD
CY2015Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1135000	USD
CY2016Q1	us-gaap	Investment Income Net InvestmentIncomeNet	852000	USD
CY2015Q4	us-gaap	Land Land	137532000	USD
CY2016Q1	us-gaap	Land Land	140634000	USD
CY2015Q1	us-gaap	Legal Fees LegalFees	104000	USD
CY2016Q1	us-gaap	Legal Fees LegalFees	126000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	990758000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	1019545000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2133218000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2159234000	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	34000000	USD
CY2016Q1	us-gaap	Line Of Credit LineOfCredit	56000000	USD
CY2015Q1	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	266500000	USD
CY2016Q1	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-22000000	USD
CY2016Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000000	USD
CY2016Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	40
CY2015Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	133714000	USD
CY2016Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	150720000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	775000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	645358000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	306885000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	856000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	828000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	801000	USD
CY2015Q4	us-gaap	Marketable Securities MarketableSecurities	72744000	USD
CY2016Q1	us-gaap	Marketable Securities MarketableSecurities	58532000	USD
CY2015Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2016Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	11000	USD
CY2015Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2016Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	11000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	9168000	USD
CY2016Q1	us-gaap	Minority Interest MinorityInterest	9117000	USD
CY2016Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	435000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5400000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11479000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43061000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14296000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38564000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41297000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	29683000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	32725000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	330000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	384000	USD
CY2015Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	893000	USD
CY2016Q1	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	450000	USD
CY2016Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	181	properties
CY2016Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	31
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	25601000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	27333000	USD
CY2015Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	52495000	USD
CY2015Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	55074000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2403000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1642000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-956000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-1013000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-4242000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-5480000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	883000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2825000	USD
CY2015Q1	us-gaap	Other Noncash Income OtherNoncashIncome	0	USD
CY2016Q1	us-gaap	Other Noncash Income OtherNoncashIncome	150000	USD
CY2015Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2016Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1665000	USD
CY2015Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1695000	USD
CY2016Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	453000	USD
CY2015Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1502000	USD
CY2016Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2015Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	28864000	USD
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	32637000	USD
CY2016Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	218000	USD
CY2015Q1	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	40773000	USD
CY2016Q1	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	20774000	USD
CY2015Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	10000	USD
CY2016Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	9463000	USD
CY2015Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3202000	USD
CY2016Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	7640000	USD
CY2015Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	436000	USD
CY2016Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	435000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3256000	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3985000	USD
CY2015Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	225000000	USD
CY2016Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	USD
CY2016Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200000000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	78084000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2015Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	0	USD
CY2016Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	3000000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	2619000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	3985000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	17049000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	30013000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2095866000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2113873000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	33109000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1133292000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	1130572000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1142460000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1836807000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1841090000	USD
CY2015Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	1346000	USD
CY2016Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	0	USD
CY2015Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	183000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	189000	USD
CY2015Q1	us-gaap	Revenues Revenues	55751000	USD
CY2016Q1	us-gaap	Revenues Revenues	59018000	USD
CY2015Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2016Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	979000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.047
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.059
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.178
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.191
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0098
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0091
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	596664	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	731662	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.74
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.65
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	871671	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	870012	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	741676	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1085010	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M25D
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M4D
CY2015Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1464000	USD
CY2016Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	980000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1139689000	USD
CY2015Q1	us-gaap	Straight Line Rent StraightLineRent	6089000	USD
CY2016Q1	us-gaap	Straight Line Rent StraightLineRent	5286000	USD
CY2015Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	11814000	USD
CY2016Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	11233000	USD
CY2015Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-1317000	USD
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37558067	shares
CY2016Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	38401647	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37645265	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38414791	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37558067	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38401647	shares
CY2016Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> - We have reclassified, for all periods presented, certain loan commitment fees paid by our borrowers, which were previously accounted for on our Consolidated Balance Sheet at December 31, 2015, as deferred revenues. The fees are now presented on our consolidated balance sheets as a contra-asset to the related loan receivable balance. The effect has been to reduce total assets and total liabilities by </font><font style="font-family:inherit;font-size:10pt;">$1,317,000</font><font style="font-family:inherit;font-size:10pt;"> on our Condensed Consolidated Balance Sheet as of December 31, 2015.</font></div></div>
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000877860-16-000126-index-headers.html	Edgar Link	pending
0000877860-16-000126-index.html	Edgar Link	pending
0000877860-16-000126.txt	Edgar Link	pending
0000877860-16-000126-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-20160331.xml	Edgar Link	completed
nhi-20160331.xsd	Edgar Link	pending
nhi-20160331_cal.xml	Edgar Link	unprocessable
nhi-20160331_def.xml	Edgar Link	unprocessable
nhi-20160331_lab.xml	Edgar Link	unprocessable
nhi-20160331_pre.xml	Edgar Link	unprocessable
nhi-3312016x10q.htm	Edgar Link	pending
nhi-3312016x10qex101.htm	Edgar Link	pending
nhi-3312016x10qex311.htm	Edgar Link	pending
nhi-3312016x10qex312.htm	Edgar Link	pending
nhi-3312016x10qex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2016 Q1 Form 10-Q Financial Statement

#000087786016000126 Filed on May 06, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2016 Q1 Form 10-Q Financial Statement

#000087786016000126 Filed on May 06, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi